Comparison of NCL-hTERT antibody reactivity and telomere repeat amplification protocol in situ in effusions

Acta Cytologica

Volumn 51, Issue 6, 2007, Pages 886-892

  Zendehrokh, Nooreldin ^a   Rehnberg, Johanna ^a   Dejmek, Annika ^a,b  

^a Malmö University Hospital   (Sweden)

^b Malmo University Hospital   (Sweden)

Author keywords

Effusion; hTERT; Immunohistochemistry; Malignancy; Mesothelial cells; Nucleolin; Telomerase; Telomere repeat amplification protocol

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EFFUSION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALIGNANT NEOPLASTIC DISEASE; MESOTHELIUM CELL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

EID: 36348939182     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325865     Document Type: Article

References (41)

1. Rye MS: Telomeres, telomerase and immortality. J Natl Cancer Inst 1995;87:884-894
2. Wright WE, Shay JW: Telomere dynamics in cancer progression and prevention: Fundamental differences in human and mouse telomere biology. Nat Med 2000;6:847-856
3. Shay JW, Zou Y, Hiyama E, Wright WE: Telomerase and cancer. Human Mol Genet 2001;10:677-685
4. Mu J, Wei LX: Telomere and telomerase in oncology. Cell Res 2002;12:1-7
5. Shay JW: Telomerase therapeutics: Telomeres recognized as a DNA damage signal. Clin Cancer Res 2003;9:3521-3525
6. Cong Y-S, Wright WE, Shay JW: Human telomerase and its regulation. Microbiol Mol Biol Rev 2002;66:407-425
7. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 1994;226:2011-2015
8. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE, Shay JW: Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1995;17:1-15
9. Norrback KF, Dahlenborg K, Carlsson R, Roos G: Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 1996;88:222-229
10. Ohyashiki K, Ohyashiki JH, Nishimaki J, Toyama K, Ebihara Y, Kato H, Wright WE, Shay JW: Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 1997;57:2100-2103
11. Zendehrokh N, Dejmek A: Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: Malignant cells, proliferative mesothelial cells, and lymphocytes. Mod Pathol 2005;18:189-196
12. Yan P, Benhattar J, Seelentag M, Stehle JC, Bosman F: Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 2004;121:391-397
13. Dejmek A, Hjerpe A: The combination of CEA, EMA and BerEp4 and hyaluronan analysis: Specifically identifies 79% of all histologically verified mesotheliomas causing an effusion. Diagn Cytopathol 2005;32:160-166
14. Nurminen M, Dejmek A, Mårtensson G, Hjerpe A: Clinical utility of liquid-chromatographic analysis of effusion for hyaluronate content. Clin Chem 1994;40:777-780
15. Yahata N, Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Ando K, Hirano T, Tsuchida T, Kato H, Shay JW, Toyama K: Telomerase activity in lung cancer cells obtained from bronchial washings. J Natl Cancer Inst 1998;90:684-690
16. Hiyama E, Hiyama K, Yokoyama T, Shay JW: Immunohistochemical detection of telomerase hTERT protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 2001;3:17-26
17. Kawakami Y, Kitamoto M, Nakanishi T, Yasui W, Tahara E, Nakayama J, Ishikawa F, Tahara H, Ide T, Kajiyama G: Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues. Oncogene 2000;19: 3888-3893
18. Frost M, Bobak JB, Gianani R, Kim N, Weinrich S, Spalding DC, Cass LG, Tompson LC, Enomoto T, Uribe-Lopez D, Shroyer KK: Localization of telomerase hTERT protein and hTR in benign mucosa dysplasia, and squamous cell carcinoma of the cervix. Am J Clin Pathol 2000;114:726-734
19. Yang SM, Zhang B, Wang JM, Liao SL, Han JH, Wei JP, Hou L: Monoclonal antibodies against human telomerase reverse transcriptase (hTERT): Preparation, characterization, and application. Hybridoma 2001;20:249-255
20. Brustmann H: Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: A clinicopathologic study. Gynecol Oncol 2005;98:396-402
21. Luzar B, Poljak M, Cör A, Klopi U, Ferlan-Marolt V: Expression of human telomerase catalytic protein in gallbladder carcinogenesis. J Clin Pathol 2005;58:820-825
22. Ito Y, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A: Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT). Anticancer Res 2005;25:509-514
23. Luzar B, Poljak M, Gale N: Telomerase catalytic subunit in laryngeal carcinogenesis: An immunohistochemical study. Mod Pathol 2005;18:406-411
24. Sabah M, Cummins R, Leader M, Kay E: Expression of human telomerase reverse transcriptase in gastrointestinal stromal tumors occurs preferentially in malignant neoplasms. Hum Pathol 2004;35:1231-1235
25. Volpi A, Bravaccini S, Medri L, Cerasoli S, Gaudio M, Amadori D: Usefulness of immunological detection of the human telomerase transcriptase. Cell Oncol 2005;27:347-353
26. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB, Brooks MW, Kaneko S, Murakami S, DeCaprio JA, Weinberg RA, Stewart SA, Hahn WC: Telomerase maintains telomere structure in normal human cells. Cell 2003;114:241-253
27. Kotoula V, Cheva A, Barbanis S, Papadimitriou CS, Karkavelas G: hTERT immunopositivity patterns in the normal brain and in astrocytic tumors. Acta Neuropathol 2006;111:569-578
28. Nagao K, Ohyashiki JH, Ohyashiki K, Tabata K, Takai K, Kameyama K, Kitano S, Kawano K, Hibi N, Kanamaru T, Hisatomi H: Expression of hTERT mRNA in a mortal liver cell line during S phase without detectable telomerase activity. Int J Mol Med 2005;15:683-688
29. Naito Y, Tagaki T, Handa O, Ishikawa T, Matsumoto N, Yoshida N, Kato H, Ando T, Takemura T, Itani K, Hisatomi H, Tsuchihashi Y, Yoshikawa T: Telomerase activity and expression of telomerase RNA component and catalytic subunits in precancerous and cancerous colorectal lesions. Tumor Biol 2001;22:374-382
30. Yano Y, Yoshida K, Osaki A, Toge T, Tahara H, Ide T, Yasui W: Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissue. Anticancer Res 2002;2:4101-4107
31. Dhaene K, Hubner R, Kumar-Singh S, Weyn B, Van Marck E: Telomerase activity in human pleural mesothelioma. Thorax 1998;53:915-918
32. Dhaene K, Wauters J, Weyn B, Timmermans JP, van Marck E: Expression profile of telomerase subunits in human pleural mesothelioma. J Pathol 2000;190:80-85
33. Cakir C, Gulluoglu MG, Yilmazbayhan D: Cell proliferation rate and telomerase activity in the differential diagnosis between benign and malignant mesothelial proliferations. Pathology 2006;38:10-15
34. Yang Y, Chen Y, Zhang C, Huang H, Weissman SM: Nucleolar localization of hTERT protein is associated with telomerase function. Exp Cell Res 2002;277:201-209
35. Etheridge KT, Banik SS, Armbruster BN, Zhu Y, Terns RM, Terns MP, Counter CM: The nucleolar localization of the catalytic subunit of human telomerase. J Biol Chem 2002;277: 24764-24770
36. Khurts S, Masutomi K, Delgermaa L, Arai K, Oishi N, Mizuno H, Hayashi N, Hahn WC, Murakami S: Nucleolin interacts with telomerase. J Biol Chem 2004;279:51508-51515
37. Wu YL, Dudognon C, Nguyen E, Hillion J, Pendino F, Tarkanyi I, Aradi J, Lanotte M, Tong JH, Chen GQ, Segal-Bendirdjian E: Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: Nucleolin and telomerase cross paths. J Cell Sci 2006;119:2797-2806
38. Sujathan K, Kannan S, Pillai KR, Chandralekha B, Amma NS, Nair MK: Significance of AgNOR count in differentiating malignant cells from reactive mesothelial cells in serous effusions. Acta Cytol 1996;40:724-728
39. Pomjanski N, Motherby H, Buckstegge B, Knops K, Rohn BL, Bocking A: Early diagnosis of mesothelioma in serous effusions using AgNOR analysis. Anal Quant Cytol Histol 2001;23:151-160
40. Chou SJ, Chen CM, Harn HJ, Chen CJ, Liu YC: In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma. J Surg Res 2001;99:75-83
41. Bjartell A, Laine S, Pettersson K, Nilsson E, Lövgren T, Lilja H: Time-resolved fluorescence in immunocytochemical detection of prostate-specific antigen in prostatic tissues sections. Histochem J 1999;31:45-52